Clinical Trials at the Inflection Point: What Sponsors Must Solve Next

Articles

Published: 29 July 2026

The next 18 to 24 months will test whether sponsors can build trials that are easier to run without weakening the evidence.

Leading clinical development teams from Astellas, Regeneron, Genentech, Roche, Bayer, Eisai, and Takeda are rethinking site strategy, patient access, protocol design, real-world evidence, and AI governance.

Discover how in the latest whitepaper: Clinical Trials at the Inflection Point: What Sponsors Must Solve Next.

Articles

Precision for Medicine

How Investigator Engagement Builds Enrollment Momentum

Published 21 September 2026 Author(s): Lisa Lopez When people talk about investigator engagement,...

Tuesday, 13 Oct 2026

Articles

Pharmaceutical Medicine – Journal

From Compliance to Strategic Partner: The Transformation of Regulatory Affairs in AstraZeneca Local Affiliates

Published 14 September 2026 Author(s): María Cristina Fernández Montero, Hannie de Munnik, Agnieszka...

Tuesday, 6 Oct 2026

Articles

Lumanity

Psychedelics: Beyond the Breakthrough

Published 6 October 2026 Author(s): Ginger Johnson An Update: From Clinical Promise to...

Tuesday, 6 Oct 2026

Articles

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

Clinical Trials at the Inflection Point: What Sponsors Must Solve Next

Dates

Topics

Formats

Organiser

Articles

How Investigator Engagement Builds Enrollment Momentum

From Compliance to Strategic Partner: The Transformation of Regulatory Affairs in AstraZeneca Local Affiliates

Psychedelics: Beyond the Breakthrough

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

You are attempting to log out of MyMA

Clinical Trials at the Inflection Point: What Sponsors Must Solve Next

Dates

Topics

Formats

Organiser

Articles

Related

How Investigator Engagement Builds Enrollment Momentum

From Compliance to Strategic Partner: The Transformation of Regulatory Affairs in AstraZeneca Local Affiliates

Psychedelics: Beyond the Breakthrough

Accept Cookies?

Enjoy Unlimited Access and Unlock Additional Features with a Free Account

You are attempting to log out of MyMA

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account